crispr-pharma

Wherever you go,

you will find us at the service of your health

CRISPR-PHARMACEUTICAL COMPANY

CRISPR, was initiated in the year 2020, aims to enhance human health by harnessing genomics to deepen our comprehension of the biology and management of human diseases. Its ultimate goal is to pave the way for a fresh wave of therapeutic approaches. CRISPR is a pharmaceutical biotechnology company dedicated to the discovery and development of novel therapeutic biologics though using CRISPR / Cas 9 gene editing and EVs in CAR T Cell Therapy.

The company’s know-how is based on an in-depth molecular and cellular understanding of crucial biological processes, such as the CRISPR/Cas 9 gene editing in CAR T Cells and the Extracellular vesicles (EVs) or exosomes produced from different cell types/cell lines with our turbulence technology to act as cell therapies for tissue regeneration, diseases such as stroke, heart failure, arthritis, immunomodulatory…

CRISPR seeking to reprograming the immune cells for a personalized attack on cancer via Autologous and Allogeneic chimeric antigen receptor (CAR) T cell therapy.

How we work

01.

Gathering data

02.

Planning

03.

Implementation

04.

Results

We know how it works!

If the plan doesn't work, change the plan but never change the goal ...

Submit

Submit your request now & get free first consultation!